Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Substance abuse treatment for people with schizophrenia.

Bellack AS, Gearon JS.

Addict Behav. 1998 Nov-Dec;23(6):749-66. Review.

PMID:
9801714
2.

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y.

Arch Gen Psychiatry. 2006 Apr;63(4):426-32.

PMID:
16585472
3.

Treatment of patients with schizophrenia and substance abuse disorders.

Tsuang J, Fong TW.

Curr Pharm Des. 2004;10(18):2249-61. Review.

PMID:
15281900
4.

Nonpharmacologic approaches to substance abuse treatment.

Carroll KM, Schottenfeld R.

Med Clin North Am. 1997 Jul;81(4):927-44. Review.

PMID:
9222261
5.

Behavioral interventions for dual-diagnosis patients.

Goldsmith RJ, Garlapati V.

Psychiatr Clin North Am. 2004 Dec;27(4):709-25. Review.

PMID:
15550289
6.

[Motivational interviewing for cannabis users with psychotic disorders].

Bonsack C, Montagrin Y, Favrod J, Gibellini S, Conus P.

Encephale. 2007 Oct;33(5):819-26. French.

PMID:
18357854
7.

[Motivational interviewing for patients with comorbid schizophrenia and substance abuse disorders: a review].

Bechdolf A, Pohlmann B, Geyer C, Ferber C, Klosterkötter J, Gouzoulis-Mayfrank E.

Fortschr Neurol Psychiatr. 2005 Dec;73(12):728-35. Review. German.

PMID:
16355315
8.

Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.

Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N, Quinn J, Palmer S, Davies L, Lowens I, McGovern J, Lewis S.

Br J Psychiatry. 2003 Nov;183:418-26.

9.

[Personality disorders and substance abuse disorders. Psychosocial strategies].

Lana Moliner F.

Actas Esp Psiquiatr. 2001 Jan-Feb;29(1):58-66. Review. Spanish.

PMID:
11333520
10.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
11.

Management of schizophrenia with substance use disorders.

Lybrand J, Caroff S.

Psychiatr Clin North Am. 2009 Dec;32(4):821-33. doi: 10.1016/j.psc.2009.09.002. Review.

PMID:
19944886
13.

Analysis of three interventions for substance abuse treatment of severely mentally ill people.

Ridgely MS, Jerrell JM.

Community Ment Health J. 1996 Dec;32(6):561-72.

PMID:
8905228
14.

The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.

Compton MT, Weiss PS, West JC, Kaslow NJ.

Soc Psychiatry Psychiatr Epidemiol. 2005 Dec;40(12):939-46. Epub 2005 Oct 25.

PMID:
16247563
15.

Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.

Horsfall J, Cleary M, Hunt GE, Walter G.

Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599. Review.

PMID:
19205964
16.

Gender differences in patients with schizophrenia and substance abuse.

Brunette MF, Drake RE.

Compr Psychiatry. 1997 Mar-Apr;38(2):109-16.

PMID:
9056130
17.

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR.

Schizophr Bull. 1998;24(4):589-608. Review.

18.

Psychosocial approaches to dual diagnosis.

Drake RE, Mueser KT.

Schizophr Bull. 2000;26(1):105-18. Review.

19.

A review of comorbidity: major mental illness and problematic substance use.

Siegfried N.

Aust N Z J Psychiatry. 1998 Oct;32(5):707-17. Review.

PMID:
9805595
20.

Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.

Potvin S, Stip E, Lipp O, Roy MA, Demers MF, Bouchard RH, Gendron A.

Am J Drug Alcohol Abuse. 2008;34(1):75-82.

PMID:
18161645
Items per page

Supplemental Content

Write to the Help Desk